Keyphrases
Gastroesophageal Reflux Disease
100%
Proton Pump Inhibitors
100%
Excessive Use
100%
Inhibitor Treatment
66%
Endoscopy-negative Reflux Disease
33%
On Demand
22%
Randomized Controlled Trial
22%
Once-daily
22%
Erosive Esophagitis
22%
Interventional Study
11%
Intensive Care Medicine
11%
Placebo Treatment
11%
Continued Use
11%
Proton Pump Inhibitor Therapy
11%
H2-receptor Antagonists
11%
Nonrandomized Studies
11%
Once-daily Dosing
11%
Medicine and Dentistry
Gastroesophageal Reflux
100%
Proton-Pump Inhibitor
100%
Systematic Review
100%
Reflux
30%
Endoscopy
30%
Diseases
30%
Drug Megadose
20%
Reflux Esophagitis
20%
Randomized Controlled Trial
20%
Intensive Care
10%
H2 Antagonist
10%
Patient with Gastroesophageal Reflux
10%
Placebo
10%
Pharmacology, Toxicology and Pharmaceutical Science
Gastroesophageal Reflux
100%
Proton Pump Inhibitor
100%
Diseases
30%
Randomized Controlled Trial
20%
Reflux Esophagitis
20%
Placebo
10%
Histamine H2 Receptor Antagonist
10%